DDAVP factor VIII concentrate and its properties in vivo and in vitro
- 1 January 1979
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 15 (1-2), 263-271
- https://doi.org/10.1016/0049-3848(79)90072-0
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Characteristics of Various Factor VIII Concentrates used in Treatment of Haemophilia ABritish Journal of Haematology, 1977
- D.D.A.V.P. IN HÆMOPHILIAThe Lancet, 1977
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975
- Genetic Variants of von Willebrand's DiseaseBMJ, 1972
- Electroimmuno AssayScandinavian Journal of Clinical and Laboratory Investigation, 1972
- Experimental and Clinical Studies on AMCA, the Antifibrinolytically Active Isomer of p‐Aminomethyl Cyclohexane Carboxylic AcidScandinavian Journal of Haematology, 1965
- The Specific Assay of Prower-Stuart Factor and Factor VIIActa Haematologica, 1961
- On an Inherited Autosomal Hemorrhagic Diathesis with Antihemophilic Globulin (AHG) Deficiency and Prolonged Bleeding Times1Acta Medica Scandinavica, 1957
- A Quantitative One-Stage Method for the Assay of ProthrombinScandinavian Journal of Clinical and Laboratory Investigation, 1949